Group 1 - Cigna Group is set to release its Q1 earnings results on May 2, with expected earnings of $6.35 per share, a decrease from $6.47 per share in the same period last year [1] - The company anticipates quarterly revenue of $60.38 billion, up from $57.25 billion a year earlier [1] - Cigna's board declared a cash dividend of $1.51 per share of its common stock on April 23 [1] Group 2 - Cigna shares experienced a decline of 1.4%, closing at $335.18 [2] - Analysts have provided various ratings and price target adjustments for Cigna, with Truist Securities maintaining a Buy rating and raising the price target from $375 to $385 [7] - UBS maintained a Buy rating but reduced the price target from $410 to $390, while Oppenheimer cut its price target from $400 to $375, both maintaining their respective ratings [7] - Raymond James reiterated a Strong Buy rating but lowered the price target from $415 to $360, and Morgan Stanley maintained an Overweight rating with a price target reduction from $403 to $379 [7]

Core Insights - Applied Industrial Technologies (AIT) reported revenue of $1.17 billion for the quarter ended March 2025, reflecting a year-over-year increase of 1.8% [1] - Earnings per share (EPS) for the quarter was $2.57, up from $2.48 in the same quarter last year, exceeding the consensus estimate of $2.40 by 7.08% [1] - The revenue surpassed the Zacks Consensus Estimate of $1.16 billion, resulting in a surprise of 0.51% [1] Financial Performance - Net Sales for Engineered Solutions reached $405.15 million, exceeding the three-analyst average estimate of $394.23 million, with a year-over-year increase of 13.5% [4] - Net Sales for Service Center Based Distribution was reported at $761.60 million, slightly below the estimated $766.60 million, representing a decline of 3.5% compared to the previous year [4] - Operating income for Engineered Solutions was $53.96 million, slightly below the estimated $55.08 million, while Operating income for Service Center Based Distribution was $107.16 million, exceeding the estimate of $99.49 million [4] Stock Performance - Shares of Applied Industrial Technologies have returned +3% over the past month, outperforming the Zacks S&P 500 composite, which saw a decline of -0.7% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Core Insights - Dominion Energy reported revenue of $4.08 billion for the quarter ended March 2025, reflecting a 12.2% increase year-over-year and a surprise of +6.76% over the Zacks Consensus Estimate of $3.82 billion [1] - Earnings per share (EPS) for the quarter was $0.93, compared to $0.55 in the same quarter last year, resulting in an EPS surprise of +20.78% against the consensus estimate of $0.77 [1] Revenue Breakdown - Total operating revenue for Dominion Energy Virginia was $2.79 billion, exceeding the average estimate of $2.63 billion by analysts, marking a year-over-year increase of +12.3% [4] - Total operating revenue from Contracted Energy was $307 million, slightly above the estimated $299.84 million, but showing a year-over-year decline of -0.3% [4] - Total operating revenue for Dominion Energy South Carolina reached $951 million, surpassing the average estimate of $920.84 million, with a year-over-year increase of +6.5% [4] Stock Performance - Over the past month, shares of Dominion Energy have returned -3.3%, compared to a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]

EOG Resources (EOG) reported $5.67 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 7.4%. EPS of $2.87 for the same period compares to $2.82 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $5.83 billion, representing a surprise of -2.75%. The company delivered an EPS surprise of +4.74%, with the consensus EPS estimate being $2.74.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how ...

CareTrust REIT (CTRE) reported $96.62 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 53.2%. EPS of $0.42 for the same period compares to $0.22 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $96.85 million, representing a surprise of -0.24%. The company delivered an EPS surprise of -2.33%, with the consensus EPS estimate being $0.43.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- a ...

Core Insights - Arthur J. Gallagher (AJG) reported revenue of $3.68 billion for the quarter ended March 2025, reflecting a year-over-year increase of 14.4% [1] - The earnings per share (EPS) for the quarter was $3.67, up from $3.49 in the same quarter last year, with an EPS surprise of +2.80% compared to the consensus estimate of $3.57 [1] Financial Performance Metrics - The total company commissions were reported at $2.25 billion, a +12.8% change year-over-year, but below the average estimate of $2.27 billion [4] - The risk management segment reported revenues before reimbursements of $373.40 million, which is a +5.8% change year-over-year, but lower than the average estimate of $382.24 million [4] - Total company fees were $984.80 million, representing a +3.5% year-over-year change, but below the average estimate of $1.06 billion [4] - The brokerage segment's supplemental revenues were $113.90 million, exceeding the average estimate of $96.15 million, with a year-over-year increase of +21.3% [4] - The brokerage segment's contingent revenues were $92.90 million, slightly above the average estimate of $91.80 million, reflecting an +8% change year-over-year [4] Stock Performance - Over the past month, shares of Arthur J. Gallagher have returned -6.8%, compared to a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

For the quarter ended March 2025, American Homes 4 Rent (AMH) reported revenue of $459.28 million, up 8.4% over the same period last year. EPS came in at $0.46, compared to $0.30 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $441.83 million, representing a surprise of +3.95%. The company delivered an EPS surprise of +2.22%, with the consensus EPS estimate being $0.45.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wa ...

Core Insights - DMC Global reported revenue of $159.29 million for Q1 2025, a year-over-year decline of 4.5%, but exceeded the Zacks Consensus Estimate by 7.37% [1] - The company's EPS for the quarter was $0.11, down from $0.21 a year ago, with a significant surprise of 237.50% compared to the consensus estimate of -$0.08 [1] Financial Performance - DMC Global's net sales for Arcadia were $65.58 million, surpassing the average estimate of $58.15 million, reflecting a year-over-year increase of 5.9% [4] - NobelClad's net sales reached $28.16 million, exceeding the two-analyst average estimate of $25.65 million, with a year-over-year change of 5% [4] - DynaEnergetics reported net sales of $65.55 million, slightly above the average estimate of $64.55 million [4] Stock Performance - Over the past month, DMC Global's shares have declined by 23.8%, contrasting with a minor decline of 0.7% in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Adaptive Biotechnologies reported a revenue of $52.44 million for the quarter ended March 2025, marking a year-over-year increase of 25.3% [1] - The earnings per share (EPS) for the same period was -$0.20, an improvement from -$0.33 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $43.15 million by 21.53%, and the EPS also surpassed the consensus estimate of -$0.28 by 28.57% [1] Performance Metrics - The ClonoSEQ test volume was reported at 23,117, slightly below the three-analyst average estimate of 23,468 [4] - Total Minimal Residual Disease (MRD) revenues reached $43.72 million, significantly above the three-analyst average estimate of $34.61 million, reflecting a year-over-year increase of 34% [4] - Total Immune Medicine revenues were $8.72 million, slightly above the estimated $8.50 million, but showed a year-over-year decline of 5.7% [4] Stock Performance - Shares of Adaptive Biotechnologies have decreased by 7.3% over the past month, compared to a decline of 0.7% in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

Core Insights - Beazer Homes reported revenue of $565.34 million for the quarter ended March 2025, reflecting a 4.4% increase year-over-year and a surprise of +4.20% over the Zacks Consensus Estimate of $542.55 million [1] - The company's EPS was $0.42, significantly lower than $1.26 in the same quarter last year, but exceeded the consensus estimate of $0.26 with a surprise of +61.54% [1] Financial Performance Metrics - Total home closings were 1,079, surpassing the two-analyst average estimate of 1,050 [4] - The average closing price from continuing operations was $515.30, slightly above the estimated $515.06 [4] - New orders, net of cancellations, totaled 1,098, lower than the average estimate of 1,414 [4] - Units in backlog were 1,526, compared to the average estimate of 1,872 [4] - The average active community count was 163, slightly below the average estimate of 165 [4] - Revenue from land sales and other was $9.31 million, significantly higher than the average estimate of $2 million, representing a year-over-year change of +220.5% [4] - Homebuilding revenue was $556.03 million, exceeding the average estimate of $540.53 million with a year-over-year change of +3.2% [4] - Gross profit from homebuilding was $84.13 million, above the average estimate of $81.64 million [4] - Gross profit from land sales and other was $1.87 million, compared to the estimated $0.80 million [4] Stock Performance - Beazer's shares have returned -6.3% over the past month, underperforming the Zacks S&P 500 composite's -0.7% change [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance in the near term [3]